IBDEI1M3 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27344,1,4,0)
 ;;=4^E87.79
 ;;^UTILITY(U,$J,358.3,27344,2)
 ;;=^5003025
 ;;^UTILITY(U,$J,358.3,27345,0)
 ;;=E21.0^^106^1349^27
 ;;^UTILITY(U,$J,358.3,27345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27345,1,3,0)
 ;;=3^Primary Hyperparathyroidism
 ;;^UTILITY(U,$J,358.3,27345,1,4,0)
 ;;=4^E21.0
 ;;^UTILITY(U,$J,358.3,27345,2)
 ;;=^331439
 ;;^UTILITY(U,$J,358.3,27346,0)
 ;;=E87.71^^106^1349^30
 ;;^UTILITY(U,$J,358.3,27346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27346,1,3,0)
 ;;=3^Transfusion Associated Circulatory Overload
 ;;^UTILITY(U,$J,358.3,27346,1,4,0)
 ;;=4^E87.71
 ;;^UTILITY(U,$J,358.3,27346,2)
 ;;=^5003024
 ;;^UTILITY(U,$J,358.3,27347,0)
 ;;=D63.1^^106^1350^1
 ;;^UTILITY(U,$J,358.3,27347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27347,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,27347,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,27347,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,27348,0)
 ;;=I12.0^^106^1350^9
 ;;^UTILITY(U,$J,358.3,27348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27348,1,3,0)
 ;;=3^HTN w/ CKD w/ Stage 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,27348,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,27348,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,27349,0)
 ;;=I95.1^^106^1350^10
 ;;^UTILITY(U,$J,358.3,27349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27349,1,3,0)
 ;;=3^Hypotension,Orthostatic
 ;;^UTILITY(U,$J,358.3,27349,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,27349,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,27350,0)
 ;;=I95.89^^106^1350^11
 ;;^UTILITY(U,$J,358.3,27350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27350,1,3,0)
 ;;=3^Hypotension,Other
 ;;^UTILITY(U,$J,358.3,27350,1,4,0)
 ;;=4^I95.89
 ;;^UTILITY(U,$J,358.3,27350,2)
 ;;=^5008079
 ;;^UTILITY(U,$J,358.3,27351,0)
 ;;=N17.9^^106^1350^12
 ;;^UTILITY(U,$J,358.3,27351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27351,1,3,0)
 ;;=3^Kidney Failure,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,27351,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,27351,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,27352,0)
 ;;=N18.5^^106^1350^3
 ;;^UTILITY(U,$J,358.3,27352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27352,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,27352,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,27352,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,27353,0)
 ;;=N18.9^^106^1350^4
 ;;^UTILITY(U,$J,358.3,27353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27353,1,3,0)
 ;;=3^Chronic Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,27353,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,27353,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,27354,0)
 ;;=N39.0^^106^1350^14
 ;;^UTILITY(U,$J,358.3,27354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27354,1,3,0)
 ;;=3^Urinary Tract Infection,Unspec Site
 ;;^UTILITY(U,$J,358.3,27354,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,27354,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,27355,0)
 ;;=R31.9^^106^1350^8
 ;;^UTILITY(U,$J,358.3,27355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27355,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,27355,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,27355,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,27356,0)
 ;;=R31.0^^106^1350^7
 ;;^UTILITY(U,$J,358.3,27356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27356,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,27356,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,27356,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,27357,0)
 ;;=R60.9^^106^1350^6
 ;;^UTILITY(U,$J,358.3,27357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27357,1,3,0)
 ;;=3^Edema,Unspec
 ;;^UTILITY(U,$J,358.3,27357,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,27357,2)
 ;;=^5019534
